Tag | Content |
---|---|
Uniprot ID | Q61313; Q8CEP1; |
Entrez ID | 21419 |
Genbank protein ID | BAB30714.2; CAA55036.1; |
Genbank nucleotide ID | NM_009334.3 |
Ensembl protein ID | ENSMUSP00000027059 |
Ensembl nucleotide ID | ENSMUSG00000025927 |
Gene name | Transcription factor AP-2-beta |
Gene symbol | Tfap2b |
Organism | Mus musculus |
NCBI taxa ID | 10090 |
Cleft type | CPO |
Developmental stage | |
Data sources | Manually collected |
Reference | 29229773 |
Functional description | Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC. AP-2-beta appears to be required for normal face and limb development and for proper terminal differentiation and function of renal tubular epithelia. |
Sequence | MHSPPRDQAA IMLWKLVENV KYEDIYEDRH DGVPSHSSRL SQLGSVSQGP YSSAPPLSHT 60 PSSDFQPPYF PPPYQPLPYH QSQDPYSHVN DPYSLNPLHQ PQQHPWGQRQ RQEVGSEAGS 120 LLPQPRAALP QLSGLDPRRD YHSVRRPDVL LHSAHHGLDA GMGDSLSLHG LGHPGMEDVQ 180 SVEDANNSGM NLLDQSVIKK VPVPPKSVTS LMMNKDGFLG GMSVNTGEVF CSVPGRLSLL 240 SSTSKYKVTV GEVQRRLSPP ECLNASLLGG VLRRAKSKNG GRSLRERLEK IGLNLPAGRR 300 KAANVTLLTS LVEGEAVHLA RDFGYICETE FPAKAVSEYL NRQHTDPSDL HSRKNMLLAT 360 KQLCKEFTDL LAQDRTPIGN SRPSPILEPG IQSCLTHFSL ITHGFGAPAI CAALTALQNY 420 LTEALKGMDK MFLNNTTNRH TSGEGPGSKT GDKEEKHRK 459 |
Abbreviation :
CLO : cleft lip only. CPO : cleft palate only.
CLP : cleft lip and palate. CL/P : cleft lip with/without cleft palate.
For humans: CL/P, CLO, CPO, and CLP. For mice: CLO, CLP, and CPO.
GO ID | GO Term | Evidence |
---|---|---|
GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding | IBA |
GO:0000978 | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ISO |
GO:0000978 | RNA polymerase II cis-regulatory region sequence-specific DNA binding | IDA |
GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific | ISO |
GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific | IDA |
GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific | IBA |
GO:0000987 | cis-regulatory region sequence-specific DNA binding | ISO |
GO:0001228 | DNA-binding transcription activator activity, RNA polymerase II-specific | IDA |
GO:0003682 | chromatin binding | ISO |
GO:0003700 | DNA-binding transcription factor activity | ISS |
GO:0003700 | DNA-binding transcription factor activity | ISO |
GO:0003713 | transcription coactivator activity | ISO |
GO:0003713 | transcription coactivator activity | IDA |
GO:0003714 | transcription corepressor activity | ISO |
GO:0003714 | transcription corepressor activity | IDA |
GO:0005515 | protein binding | IPI |
GO:0042803 | protein homodimerization activity | ISO |
GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process | IMP |
GO:0043565 | sequence-specific DNA binding | ISS |
GO:0043565 | sequence-specific DNA binding | ISO |
GO:0046982 | protein heterodimerization activity | ISO |
GO:0046983 | protein dimerization activity | ISO |
GO ID | GO Term | Evidence |
---|---|---|
GO:0000122 | negative regulation of transcription by RNA polymerase II | ISO |
GO:0001822 | kidney development | IMP |
GO:0003091 | renal water homeostasis | IMP |
GO:0006006 | glucose metabolic process | ISS |
GO:0006006 | glucose metabolic process | ISO |
GO:0006355 | regulation of transcription, DNA-templated | ISS |
GO:0006355 | regulation of transcription, DNA-templated | ISO |
GO:0006357 | regulation of transcription by RNA polymerase II | IBA |
GO:0006366 | transcription by RNA polymerase II | IDA |
GO:0006915 | apoptotic process | IEA |
GO:0007423 | sensory organ development | IEP |
GO:0008284 | positive regulation of cell population proliferation | ISO |
GO:0008284 | positive regulation of cell population proliferation | IMP |
GO:0008285 | negative regulation of cell population proliferation | ISS |
GO:0008285 | negative regulation of cell population proliferation | ISO |
GO:0010842 | retina layer formation | IEA |
GO:0010960 | magnesium ion homeostasis | IMP |
GO:0030510 | regulation of BMP signaling pathway | IMP |
GO:0035136 | forelimb morphogenesis | IMP |
GO:0035137 | hindlimb morphogenesis | IMP |
GO:0035810 | positive regulation of urine volume | IMP |
GO:0035909 | aorta morphogenesis | IMP |
GO:0042127 | regulation of cell population proliferation | IBA |
GO:0042493 | response to drug | IEA |
GO:0042593 | glucose homeostasis | IMP |
GO:0043066 | negative regulation of apoptotic process | ISO |
GO:0043066 | negative regulation of apoptotic process | IMP |
GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | IEA |
GO:0043524 | negative regulation of neuron apoptotic process | IGI |
GO:0043525 | positive regulation of neuron apoptotic process | ISS |
GO:0043525 | positive regulation of neuron apoptotic process | ISO |
GO:0043588 | skin development | IEP |
GO:0045444 | fat cell differentiation | IEP |
GO:0045595 | regulation of cell differentiation | ISS |
GO:0045595 | regulation of cell differentiation | ISO |
GO:0045892 | negative regulation of transcription, DNA-templated | ISS |
GO:0045892 | negative regulation of transcription, DNA-templated | ISO |
GO:0045893 | positive regulation of transcription, DNA-templated | ISO |
GO:0045944 | positive regulation of transcription by RNA polymerase II | ISO |
GO:0045944 | positive regulation of transcription by RNA polymerase II | IDA |
GO:0045944 | positive regulation of transcription by RNA polymerase II | IMP |
GO:0048485 | sympathetic nervous system development | IGI |
GO:0050796 | regulation of insulin secretion | ISS |
GO:0050796 | regulation of insulin secretion | ISO |
GO:0055062 | phosphate ion homeostasis | IMP |
GO:0055074 | calcium ion homeostasis | IMP |
GO:0055075 | potassium ion homeostasis | IMP |
GO:0055078 | sodium ion homeostasis | IMP |
GO:0072017 | distal tubule development | IMP |
GO:0072044 | collecting duct development | IMP |
GO:0072210 | metanephric nephron development | IEP |
GO:0097070 | ductus arteriosus closure | IMP |
GO:0097275 | cellular ammonia homeostasis | IMP |
GO:0097276 | cellular creatinine homeostasis | IMP |
GO:0097277 | cellular urea homeostasis | IMP |
GO ID | GO Term | Evidence |
---|---|---|
GO:0005623 | cell | IEA |
GO:0005634 | nucleus | ISS |
GO:0005634 | nucleus | ISO |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-MMU-212436 | Generic Transcription Pathway | IEA |
R-MMU-73857 | RNA Polymerase II Transcription | IEA |
R-MMU-74160 | Gene expression (Transcription) | IEA |
R-MMU-8864260 | Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | IEA |
R-MMU-8866904 | Negative regulation of activity of TFAP2 (AP-2) family transcription factors | IEA |
R-MMU-8866907 | Activation of the TFAP2 (AP-2) family of transcription factors | IEA |
Pfam ID | Pfam Term |
---|---|
PF03299 | TF_AP-2 |